Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
about
Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment ConsiderationsPotential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancerEstrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapyHormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the kneeEstrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin.Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cellsEstrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Selectively targeting estrogen receptors for cancer treatment.Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.New insights on the role of hormonal therapy in ovarian cancerEstrogen receptor beta: an overview and updateWAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cellsThe role of hormonal factors and endocrine therapy in ovarian cancer.Hormone response in ovarian cancer: time to reconsider as a clinical target?Therapeutic significance of estrogen receptor β agonists in gliomas.Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.Toxicological mechanism of endocrine disrupting chemicals:is estrogen receptor involved?Estrogen inhibits colon polyp formation by reducing angiogenesis in a carcinogen-induced rat model.Genistein as a Potential Anticancer Agent against Ovarian Cancer.Risks and benefits of dietary isoflavones for cancer.Ovarian epithelial tumors and reproductive factors: a systematic review.Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality.Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis.Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer.Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer.Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women
P2860
Q26751021-2F927A09-6B4B-4EFF-9194-C74D613F9915Q27319512-9DCDE2AB-6D3A-43B9-9346-8B7E2113DB38Q28109453-C6D32B20-8E6A-49D7-99ED-9D4EA557B7B3Q28706277-00310F54-ACAB-4F75-BCA4-51333E5763B4Q33569877-8C9EC998-81E0-4270-BC29-4D910FDA9018Q33633056-4163406A-39C7-45FA-9041-924BACED11C0Q33642747-6EB0A358-B250-4781-B40F-FD3949E78C72Q33651509-0E8AEF4D-A8D1-48EC-87E2-734229510E4AQ33932856-FBD7B052-B7DB-4129-8CAB-24966CB990BBQ34022694-306E8CA2-4837-4245-9175-C315F49BDD05Q34349374-36D48BBD-8F2E-4892-B731-82EB4D18BAC4Q34524093-D6CE7120-0E5F-413D-B305-B528CB260689Q34950615-9B74AB1F-2B21-45F4-A5DE-E5ABCE96ED72Q36001247-D9D1A1DC-33D0-41CC-8F99-EB8ACD98530CQ36478020-88E56659-DD9A-4BE4-AFE0-BDC0A53B8EB4Q36629304-30E39C1E-B4CD-4903-A429-CF66A8F5527DQ36936727-C4DD9667-E0A0-4A16-A327-FCA9E783F711Q36966197-6E3B2EC0-C889-40C8-A11A-ABABF8D5B8DCQ37039582-FC894E06-7EC5-46AD-9628-E0D57C5CB873Q37143825-4DF47A5F-0E24-4F2C-B8B4-B3634DC02C55Q37145584-450A6928-2AFC-469F-B689-636FB2E63344Q37326623-0AE2C77C-F006-4A1E-AF0B-40AA65D7D829Q37358862-3DD8B95E-EC68-4778-8FC1-A2E3A2A2338AQ37618157-3C9AECED-C574-48BB-8B83-45B5875B55FCQ37857841-3DED0372-8BE3-4BA4-829A-0FC03DD9EB5EQ38090489-FCFF3A41-5E24-4337-AB9E-5D3E3ADAA7ECQ41472874-39B277FE-CD36-4D10-A966-0590B4C8B1A3Q41585965-AFBC55C8-E6DF-4E50-88B6-1A9E4F1A8A67Q43427677-DA8C58DF-F208-47AB-BC9E-B9A93EB770A4Q50107365-C15672D3-D317-48E3-9B10-B1F558CD7797Q51734194-F9C9721A-E479-472F-83DA-FE79934E4179Q53287498-32DB3289-1D4D-4CF4-AA0F-9F1499A9326EQ55228036-939EF17C-96F2-4DA6-AD90-C74D219E0303Q57764733-DB6CCE09-3B6C-4CCA-9210-8297509DA8AD
P2860
Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
@en
type
label
Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
@en
prefLabel
Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
@en
P2093
P356
P1476
Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
@en
P2093
Claus Lattrich
Diana Mitter
Georg Pfeiler
Gerhard Piendl
Olaf Ortmann
Oliver Treeck
P304
P356
10.1677/JOE-07-0087
P407
P577
2007-06-01T00:00:00Z